The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Vitamin D-Metabolite Ratio Predicts Fracture Risk Better than 25(OH)D

Vitamin D-Metabolite Ratio Predicts Fracture Risk Better than 25(OH)D

December 14, 2017 • By Anne Harding

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Vitamin D-metabolite ratio (VMR) may be a better marker of bone health than 25(OH)D (25-hydroxyvitamin D), a new study suggests.

You Might Also Like
  • Vitamin D, Calcium Supplements May Not Lower Fracture Risk
  • Bone Mineral Density Most Important Determinant of Fracture Risk
  • After Hip Fracture, Earlier Osteoporosis Drug Initiation Tied to Lower Subsequent Fracture Risk
Also By This Author
  • Tai Chi at Least as Good as Aerobic Exercise for Fibromyalgia

“The parameter that’s currently used to assess vitamin D status, 25(OH)D, is a flawed measure because it doesn’t consistently associate with important bone outcomes like hip fractures,” Dr. Charles Ginsberg of Veterans Affairs San Diego Healthcare System, who helped conduct the study, told Reuters Health in a telephone interview. The findings were published online November 16 in Bone.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Ginsberg and his colleagues looked at data from the Cardiovascular Health Study on 890 community-dwelling elders, who had a mean 25(OH)D of 28 ng/mL. They also measured the VMR, or the ratio of the catabolic product 24,25(OH)2D to 25(OH)D.

A 1% increase in VMR, 25(OH)D, or 24,25(OH)2D was associated with 0.26%, 0.32%, 0.25% lower parathyroid hormone (PTH) levels, respectively (P<0.05 for all). Bone mineral density (BMD) data were available for 358 study participants. There was no association between 25(OH)D or VMR and BMD, but there was a modest association between increased 24,25(OH)2D and higher hip BMD.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

During follow-up of 8.4 years, 289 hip fractures occurred. Risk of hip fracture fell significantly with increased 24,25(OH)2D and VMR (hazard ratio per standard deviation, 0.73 and 0.74, respectively). However, there was no significant association between 25(OH)D and hip fracture risk.

A person in the highest quartile of VMR would have half the risk of hip fracture compared to someone in the bottom quartile, Dr. Ginsberg noted.

While Americans spend billions of dollars on vitamin D supplements, he added, basing the need for supplementation on 25(OH)D levels may not identify people who would truly benefit. “That’s not necessarily the number we should be following; perhaps we should be following the VMR,” he said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The next step, according to Dr. Ginsberg, will be to see if increasing an individual’s VMR reduces their fracture risk. VMR could also be used to look at levels of vitamin D in relation to the risk of multiple sclerosis and several other illnesses, he added.

Reference

  1. Ginsberg C, Katz R, de Boer IH, et al.The 24,25 to 25-hydroxyvitamin D ratio and fracture risk in older adults: The cardiovascular health study. Bone. 2017 Nov 16;107:124-130. [Epub ahead of print]

Filed Under: Conditions, Drug Updates Tagged With: 25(OH)D (25-hydroxyvitamin D), bone health marker, fracture risk, Fractures, vitamin D-metabolite ratio

You Might Also Like:
  • Vitamin D, Calcium Supplements May Not Lower Fracture Risk
  • Bone Mineral Density Most Important Determinant of Fracture Risk
  • After Hip Fracture, Earlier Osteoporosis Drug Initiation Tied to Lower Subsequent Fracture Risk
  • Bisphosphonates May Limit Fracture Risk in Users of Oral Glucocorticoids

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)